Parkinson's Foundation

Parkinson's Foundation Launches #ABCsOfPD Campaign for Parkinson's Awareness Month

Retrieved on: 
Tuesday, April 2, 2024
MTPA, Exercise, PD, Partnership, Advisory Council, Health, Mental health, Parkinson's Foundation, Parkinson's disease, Wellness, Mitsubishi Tanabe Pharma, Pharmaceutical industry

NEW YORK and MIAMI, April 2, 2024 /PRNewswire/ -- The Parkinson's Foundation honors Parkinson's Awareness Month with the launch of a new campaign, #ABCsOfPD .

Key Points: 
  • NEW YORK and MIAMI, April 2, 2024 /PRNewswire/ -- The Parkinson's Foundation honors Parkinson's Awareness Month with the launch of a new campaign, #ABCsOfPD .
  • "I'm happy and humbled to be raising awareness about the importance of exercise during Parkinson's Awareness Month," said Cindy Finestone, member of the Parkinson's Foundation People with Parkinson's Advisory Council.
  • The Parkinson's Foundation is also happy to announce their partnership with Mitsubishi Tanabe Pharma America (MTPA) this Parkinson's Awareness Month.
  • "This Parkinson's Awareness Month, we're proud to partner with the Parkinson's Foundation to help raise awareness and share important resources with the PD community."

Parkinson's Foundation and Rock Steady Boxing Announce National Team Partnership of Moving Day, a Walk for Parkinson's

Retrieved on: 
Tuesday, March 26, 2024
Diagnosis, Depression, Moving Day, Organization, Exercise, Walking, Disease, PD, Sports club, Parkinson's Foundation, Anxiety, Parkinson's disease, Quality of life, Alzheimer's disease, Fatigue, Movement, Rocksteady, Neurodegenerative disease, Palladium

INDIANAPOLIS and NEW YORK and MIAMI, March 26, 2024 /PRNewswire/ -- Rock Steady Boxing, a nonprofit gym that provides a unique exercise program specifically designed for Parkinson's disease (PD), has partnered with the Parkinson's Foundation as a National Team for Moving Day, a Walk for Parkinson's. Moving Day is the Foundation's signature fundraising event and a movement for more awareness, funding, and understanding of PD. As a National Team, Rock Steady will strive to raise awareness for PD, enhance company culture, and increase reach by connecting with thousands of other supporters across the country.

Key Points: 
  • As a National Team, Rock Steady will strive to raise awareness for PD, enhance company culture, and increase reach by connecting with thousands of other supporters across the country.
  • "At Rock Steady, we are very excited about serving as a National Team for Parkinson's Foundation Moving Day events around the country," said Ryan Cotton, president and CEO of Rock Steady Boxing.
  • Founded in 2006, Rock Steady is one of three organizations that is an Accredited Exercise Education program by the Parkinson's Foundation.
  • The Parkinson's Foundation will also expand its footprint by bringing exercise programs like Rock Steady to three all-new Moving Day event locations this year.

Asha Therapeutics to Present at AD/PD™ 2024 International Conference and Announces Clinical Development Plan for Lead Programs Anticipated to Enter Clinical Trials this Year and Welcomes Two New SAB Members

Retrieved on: 
Friday, March 8, 2024
Technology, Biotechnology, Health, Other Health, Pharmaceutical, Oncology, Other Science, Other Technology, Research, Software, General Health, Science, Data Management, Clinical Trials, Community health, GSK, AbbVie, Huntington's disease, University, Mathematics, Emory University, Behavioral neurology, Pathology, School, Alzheimer's disease, Johnson & Johnson, Drug design, Gold, Bristol Myers Squibb, Johns Hopkins, Disorder, Psychiatry, Derek, UCB, Computer science, American Neurological Association, Asha, Parkinson's Foundation, Conference, Chemistry, Safety, Amelioration, CNS, Behavioural sciences, Medical school, MD, Neurology, Patient, Florida College, Disease, Publication, DRS, Pharmaceutical industry

Dr. Heckmann’s presentation is titled ASHA-091: Novel Pharmacological Targeting of Mitochondrial Dysfunction to Ameliorate Parkinson’s & Alzheimer’s Disease Pathology.

Key Points: 
  • Dr. Heckmann’s presentation is titled ASHA-091: Novel Pharmacological Targeting of Mitochondrial Dysfunction to Ameliorate Parkinson’s & Alzheimer’s Disease Pathology.
  • ASHA-091 restores normal mitochondrial function and has demonstrated disease modifying efficacy as a functional cure in preclinical disease models.
  • In preparation for clinical transition, Asha has appointed Dr. Michael Gold and Dr. Allan Levey to their Scientific Advisory Board.
  • Their expertise comes at a pivotal moment for Asha as we transition our first-in-class lead programs designed using our PRISM™ technology to clinical trials.

Parkinson's Foundation to Accelerate Research Through Expanded Genetic Testing and Counseling Study

Retrieved on: 
Tuesday, February 6, 2024
Partnership, Ageing, Knowledge, ASAP, Parkinson's disease, Research, NIH, Genetics, Gene, Columbia University, Genetic testing, Physician, Parkinson's Foundation, Disease, Science, Genetic counseling, Genetic, National Institute on Aging, Bangladesh Technical Education Board, Doctor of Philosophy, WGS, PD, Pharmaceutical industry

NEW YORK and MIAMI, Feb. 6, 2024 /PRNewswire/ -- Through its Global Parkinson's Genetics Program (GP2), Aligning Science Across Parkinson's (ASAP) has awarded the Parkinson's Foundation a grant that will significantly expand its landmark international genetics study, PD GENEration: Mapping the Future of Parkinson's Disease. The study provides genetic testing and genetic counseling to people with Parkinson's disease (PD). ASAP's funding will allow the Foundation to accelerate the study's impact by focusing on those who have been historically underrepresented in research.

Key Points: 
  • The study provides genetic testing and genetic counseling to people with Parkinson's disease (PD).
  • ASAP's funding will allow the Foundation to accelerate the study's impact by focusing on those who have been historically underrepresented in research.
  • It is a patient-facing research study," said Parkinson's Foundation Senior Vice President and Chief Scientific Officer James Beck, PhD.
  • Fox Foundation for Parkinson's Research is ASAP's implementation partner and issued the grants on behalf of ASAP and GP2.

Aspen Neuroscience to Present at Future of Parkinson's Disease Conference

Retrieved on: 
Thursday, November 30, 2023
Parkinson's disease, R&D, SAN, Senior, Aspen, PD, Disease, Phase 1, Dopamine, Neuron, Future, Parkinson's Foundation, Doctor of Philosophy

SAN DIEGO and AUSTIN, Texas, Nov. 30, 2023 /PRNewswire/ -- This week, Aspen Neuroscience will present to the Parkinson's community at the Future of Parkinson's Disease conference, held November 30 – December 3, in Austin.

Key Points: 
  • SAN DIEGO and AUSTIN, Texas, Nov. 30, 2023 /PRNewswire/ -- This week, Aspen Neuroscience will present to the Parkinson's community at the Future of Parkinson's Disease conference, held November 30 – December 3, in Austin.
  • The joint annual conference is hosted by the Parkinson's Foundation and the Parkinson Study Group.
  • In addition to multiple scientific presentations, Aspen Chief Executive Officer Damien McDevitt, PhD, and co-founder and Senior Vice President of R&D, Andres Bratt-Leal, PhD, will present updates on company progress for upcoming Phase 1 clinical trials for ANPD001, a personalized (autologous) cell therapy under investigation to treat PD by replacing lost dopamine neurons.
  • The Aspen Neuroscience schedule of presentations includes:

Parkinson's Foundation Requesting Applications for 2024 Community Grants

Retrieved on: 
Thursday, November 9, 2023
PD, Health, Parkinson's Foundation, Life, Parkinson's disease, Parkinson, Organization, Advisory Council, Community, Pharmaceutical industry

NEW YORK and MIAMI, Nov. 9, 2023 /PRNewswire/ -- The Parkinson's Foundation has announced it is accepting applications for $1 million in community grant funding.

Key Points: 
  • NEW YORK and MIAMI, Nov. 9, 2023 /PRNewswire/ -- The Parkinson's Foundation has announced it is accepting applications for $1 million in community grant funding.
  • The 2024 community grants cycle will support health, wellness and educational programs that address unmet needs in local Parkinson's disease (PD) communities.
  • Community grants range from $10,000 to $25,000 per application, and the funding period will occur from July 1, 2024, to June 30, 2025.
  • Applications are due Jan. 31, 2024, and recipients will be announced in July 2024.

Parkinson's Foundation and CurePSP Announce Partnership for Launch of Special Programming for Healthcare Professionals

Retrieved on: 
Thursday, September 21, 2023
Communication, Partnership, PD, Parkinson's Foundation, Advocacy, Health care, Corticobasal degeneration, Multiple system atrophy, Learning Lab, Parkinson, Social, Organization, Parkinson's disease, Patient, MSA, Physician, Nursing, CBD, Dysautonomia, Parkinsonism, Diagnosis, The Learning Lab, PSP, Disease, Pharmaceutical industry

NEW YORK and MIAMI, Sept. 21, 2023 /PRNewswire/ -- The Parkinson's Foundation today announced the launch of a partnership with CurePSP on the development of a multi-part educational program geared towards healthcare professionals.

Key Points: 
  • NEW YORK and MIAMI, Sept. 21, 2023 /PRNewswire/ -- The Parkinson's Foundation today announced the launch of a partnership with CurePSP on the development of a multi-part educational program geared towards healthcare professionals.
  • The program focuses on "atypical Parkinsonian syndromes," including: progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA).
  • "We want to help physicians, nurses, rehabilitation therapists, social workers and other healthcare professionals to better understand distinct needs and care considerations with atypical Parkinsonism."
  • Healthcare professionals can access this new accredited podcast on the Learning Lab.

Parkinson's Foundation Announces Inaugural "A Day to Reach Further"

Retrieved on: 
Monday, September 18, 2023
Parkinson's Foundation, Parkinson's disease, Parkinson, PD, Research, Social media, Disease, Pharmaceutical industry

MIAMI and NEW YORK, Sept. 18, 2023 /PRNewswire/ -- The Parkinson's Foundation today announced the launch of its inaugural day of giving, "A Day to Reach Further," to encourage communities to raise awareness of Parkinson's disease (PD) while raising funds to accelerate PD research, improve care and increase access to quality-of-life programs. The 24-hour event aims to support the Reach Further campaign's four-year fundraising goal of $30 million. More than half of the goal has been raised in the past two years.

Key Points: 
  • – Day of Giving on Tuesday, Sept. 19 –
    MIAMI and NEW YORK, Sept. 18, 2023 /PRNewswire/ -- The Parkinson's Foundation today announced the launch of its inaugural day of giving, " A Day to Reach Further ," to encourage communities to raise awareness of Parkinson's disease (PD) while raising funds to accelerate PD research, improve care and increase access to quality-of-life programs.
  • The 24-hour event aims to support the Reach Further campaign's four-year fundraising goal of $30 million.
  • "Having the entire Parkinson's community participate in "A Day to Reach Further" will make for an amazing collective effort toward making life better for people living with the disease and their loved ones," said Parkinson's Foundation President and CEO John L. Lehr.
  • Supporters who participate in "A Day to Reach Further" will be thanked with a special invitation to future research webinars.

UT Health Science Center San Antonio recognized as Parkinson's Foundation Comprehensive Care Center

Retrieved on: 
Tuesday, August 1, 2023
Workforce, Huntington's disease, Deep brain stimulation, Hallucination, University, Center of excellence, Tic, Parkinson's Foundation, University of Texas System, University of Texas Health Science Center at San Antonio, Senior counsel, DSM-IV codes, Therapy, Health, Parkinson's disease dementia, Quality of life, UT Health San Antonio Cancer Center, Research, Brain, Neurology, Department of Neurology, Xuanwu hospital, Dystonia, Bone, Movement, Teaching hospital, Essential tremor, Pain, Social, DBS, Electrode, Parkinson's disease, Neurosurgery, MD, Patient, SAN, Person-centered therapy, Rush Alzheimer's Disease Center, Long School, Long School of Medicine, Movement disorder, Bleeding, Memory, Skin, Disease, Pharmaceutical industry, Nursing, Veterinary medicine, Dentistry, Central Texas

SAN ANTONIO, Aug. 1, 2023 /PRNewswire-PRWeb/ -- The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been designated a Parkinson's Foundation Comprehensive Care Center, the first of its kind in the state of Texas.

Key Points: 
  • Advanced multidisciplinary care for Parkinson's disease is available at The University of Texas Health Science Center at San Antonio, which this summer was named a Parkinson's Foundation Comprehensive Care Center.
  • SAN ANTONIO, Aug. 1, 2023 /PRNewswire-PRWeb/ -- The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been designated a Parkinson's Foundation Comprehensive Care Center, the first of its kind in the state of Texas.
  • The UT Health San Antonio Movement Disorders Center is also recognized as a Huntington's Disease Center of Excellence and provides comprehensive care for patients with Huntington's disease.
  • The University of Texas Health Science Center at San Antonio (UT Health San Antonio), a primary driver for San Antonio's $44.1 billion health care and biosciences sector, is the largest academic research institution in South Texas with an annual research portfolio of more than $360 million.

Parkinson's Foundation Awards Grants in 35 States for Parkinson's Community Programs

Retrieved on: 
Tuesday, July 25, 2023
Exercise, Parkinson's Foundation, Parkinson's disease, Community, PD, Mental health, Investment, Parkinson, Pharmaceutical industry, Nursing

NEW YORK and MIAMI, July 25, 2023 /PRNewswire/ -- The Parkinson's Foundation today announced the recipients of nearly $1 million in community grants for Parkinson's disease (PD) programs across the U.S.

Key Points: 
  • NEW YORK and MIAMI, July 25, 2023 /PRNewswire/ -- The Parkinson's Foundation today announced the recipients of nearly $1 million in community grants for Parkinson's disease (PD) programs across the U.S.
  • The programs funded by the Foundation will benefit people with PD in 35 states.
  • The Foundation invests in community programs that make an impact in local communities and help people live better with PD by providing support for unmet health, wellness, and educational needs.
  • "Community-based grants empower leaders of meaningful Parkinson's programs who both understand and are equipped to address the local community's most pressing needs," said Parkinson's Foundation President and CEO John L. Lehr.